Tuberculosis, commonly called TB, is an infection caused by bacteria called Mycobacterium tuberculosis. This disease has affected humans for thousands of years—there's even evidence of TB in ancient Egyptian mummies. Today, TB remains a serious global health concern. According to the World Health Organization, approximately 10 million people develop active TB disease each year worldwide, with about 1.2 million TB-related deaths occurring annually.
Learn About Paying Your FGUA Bill Online →
TB primarily spreads through the air. When a person with TB of the lungs or throat coughs, sneezes, speaks, or sings, they release tiny droplets containing the bacteria into the air. These droplets can travel several feet and be inhaled by other people. This is different from how most other infections spread—you cannot catch TB by shaking hands, sharing food or drinks, or touching someone's clothing or skin. The bacteria must enter the lungs to cause infection.
Not everyone exposed to TB bacteria becomes sick. When TB bacteria enter your lungs, your immune system may be strong enough to stop the infection immediately. Other times, your body walls off the bacteria, keeping it dormant. This is called latent TB infection. A person with latent TB has bacteria in their body but is not sick and cannot spread TB to others. However, someone with active TB disease—where the bacteria multiply and damage the lungs—can transmit the disease and typically shows symptoms.
Close, prolonged contact increases transmission risk. Healthcare workers, family members, and people living in crowded conditions face higher exposure. Children under five and people with weakened immune systems are at greater risk of developing active TB if exposed. Understanding this distinction between latent infection and active disease is crucial for recognizing your own risk and knowing when to seek medical information.
Practical Takeaway: TB spreads through air when infected people cough or speak, not through casual contact. Knowing whether you've had close contact with someone who has active TB helps you understand whether you should learn about testing and prevention options.
Active TB disease develops symptoms gradually over weeks or months, which distinguishes it from acute illnesses like the flu. The classic signs include a persistent cough lasting more than three weeks, chest pain or discomfort that worsens with breathing or coughing, coughing up blood or blood-tinged sputum, and sometimes a hoarse voice. Beyond respiratory symptoms, people with active TB often experience fatigue, weakness, fever (usually occurring in the afternoon or evening), night sweats that may soak clothing and bedding, and unintended weight loss.
Free Guide to Pay by Plate Illinois Billing →
The severity and timing of symptoms vary. Some people develop symptoms quickly while in others it takes months. The length of symptom duration before seeking medical attention matters—longer delays mean more opportunity for TB bacteria to damage lung tissue and more time the person might unknowingly expose others. This is why understanding these warning signs matters; recognizing them early allows someone to contact a healthcare provider promptly.
TB can affect parts of the body beyond the lungs, called extrapulmonary TB. This occurs in about 15-20% of TB cases and can involve the lymph nodes, bones, joints, kidneys, brain, or other organs. Symptoms depend on which organ is affected. For instance, TB of the lymph nodes causes swollen glands, while TB of the spine causes back pain. These forms are harder to detect and may require different diagnostic approaches.
Certain populations experience TB symptoms at different rates or with different severity. Children with TB often have fewer symptoms and may show mainly fever and weight loss. Older adults might have mild symptoms easily confused with other chronic conditions. People with HIV or other conditions affecting immunity may develop severe TB disease more rapidly. Recognizing this variation helps people understand why symptoms alone don't confirm TB and why medical evaluation remains important.
People with latent TB infection show no symptoms at all—they feel completely normal. The only way to know latent TB is present is through specific testing. This is why TB testing recommendations matter for certain groups: people exposed to someone with active TB, healthcare workers, people with HIV, and those in high-risk living situations should understand testing options even without symptoms.
Practical Takeaway: A cough lasting more than three weeks, especially with fever or night sweats, warrants medical evaluation. However, latent TB causes no symptoms, so testing may be recommended even for healthy people based on exposure risk or occupation.
Two main types of tests detect TB infection: the tuberculin skin test (TST) and blood tests called interferon-gamma release assays (IGRAs). The TST, also called the Mantoux test, involves injecting a small amount of purified protein derivative (PPD) under the skin of the forearm. A healthcare worker examines the injection site 48 to 72 hours later, measuring any raised, hardened area (called induration). The size of the reaction, measured in millimeters, indicates the result. Different cutoff measurements apply based on individual risk factors—someone with HIV or recent TB exposure may be considered to have a positive test at 5mm, while someone with low risk might need 15mm or more.
Free Guide to Mold Removal Methods for Walls →
IGRAs are blood tests that measure how the immune system reacts to TB antigens. These tests are more specific than TST and less affected by previous BCG vaccination (a TB vaccine given in some countries). IGRA results come back as positive, negative, or indeterminate. Blood tests can be completed in one visit without requiring a follow-up appointment, unlike TST which requires two visits.
A positive TB test means TB bacteria is in your body. It does not distinguish between latent and active TB. To determine which type, healthcare providers order a chest X-ray and sometimes sputum tests (samples of material coughed up from the lungs). A chest X-ray shows characteristic patterns if active TB is present. Sputum samples are examined under a microscope for TB bacteria and may be sent for culture testing, which can take weeks but confirms TB and checks which medications work against it.
A negative TB test generally means TB infection is not present, though false negatives can occur in severely immunocompromised people or in the first weeks after infection. If symptoms suggest TB but the initial test is negative, healthcare providers may repeat testing or order imaging studies. This is why symptoms and exposure history matter alongside test results.
For people with latent TB, additional testing and evaluation help predict progression risk. People with latent TB and recent infection (diagnosed within two years), those aged 35 or younger, and those with certain medical conditions face higher risk of developing active disease. Healthcare providers use these factors to counsel people about treatment options for latent TB.
Practical Takeaway: TB tests detect infection but don't show symptoms. A positive test requires additional imaging and possibly sputum testing to confirm whether TB is active or latent and to guide treatment decisions.
Active TB disease requires a specific, standardized medication regimen. The standard treatment involves taking four drugs—isoniazid, rifampicin, pyrazinamide, and ethambutol—for two months, followed by isoniazid and rifampicin for four more months. This six-month total course is designed to kill TB bacteria and prevent drug resistance. Missing doses or stopping early can lead to treatment failure and drug-resistant TB, which requires longer, more complicated treatment with medications that have more side effects.
How to Delete Your Fitbit Account Guide →
Latent TB treatment aims to prevent progression to active disease. The most common approach is isoniazid taken daily for six to nine months. Alternative regimens exist for people who cannot tolerate isoniazid or prefer shorter courses. For example, rifampicin and pyrazinamide taken together for two months is an option, though this combination has higher rates of liver toxicity. Newer regimens like combining rifapentine with isoniazid for three months weekly doses offer shorter treatment periods. Healthcare providers discuss these options with patients to find an approach they can complete.
Side effects from TB medications are manageable but important to understand. Isoniazid can cause peripheral neuropathy (nerve damage), which vitamin B6 supplementation helps prevent. Rifampicin turns urine and other body secretions orange and can interact with many other medications, including birth control pills. Pyrazinamide may cause joint pain and increase uric acid levels. Ethambutol can rarely affect color vision. Most side effects are mild and decrease over time, but any concerning
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.